(Q34595998)

3 August 2017

title

Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury (English)

1 reference

3 August 2017

1 reference

H Cardinal

1

1 reference

3 August 2017

M Dieudé

2

1 reference

3 August 2017

N Brassard

3

1 reference

3 August 2017

S Qi

4

1 reference

3 August 2017

N Patey

5

1 reference

3 August 2017

M Soulez

6

1 reference

3 August 2017

D Beillevaire

7

1 reference

3 August 2017

F Echeverry

8

1 reference

3 August 2017

C Daniel

9

1 reference

3 August 2017

Y Durocher

10

1 reference

3 August 2017

F Madore

11

1 reference

3 August 2017

M J Hébert

12

1 reference

3 August 2017

language of work or name

English

0 references

publication date

22 February 2013

1 reference

American Journal of Transplantation

3 August 2017

published in

1 reference

3 August 2017

volume

13

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

861-874

1 reference

Impact of the Banff '97 classification for histological diagnosis of rejection on clinical outcome and renal function parameters after kidney transplantation

3 August 2017

cites work

1 reference

Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival.

21 January 2018

1 reference

Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation

21 January 2018

1 reference

Non-MHC antigenic targets of the humoral immune response in transplantation

21 January 2018

1 reference

Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection

21 January 2018

1 reference

Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.

21 January 2018

1 reference

Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation.

21 January 2018

1 reference

Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis

21 January 2018

1 reference

The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection.

21 January 2018

1 reference

Urinary proteomic analysis of chronic allograft nephropathy

21 January 2018

1 reference

Banff 07 classification of renal allograft pathology: updates and future directions

21 January 2018

1 reference

Epidermal growth factor and perlecan fragments produced by apoptotic endothelial cells co-ordinately activate ERK1/2-dependent antiapoptotic pathways in mesenchymal stem cells.

21 January 2018

1 reference

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

21 January 2018

1 reference

Kidney transplantation: mechanisms of rejection and acceptance

21 January 2018

1 reference

Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining.

21 January 2018

1 reference

Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat.

21 January 2018

1 reference

Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/AJT.12168

1 reference

release_zocld2riqnht5mx55uij4mimwi

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zocld2riqnht5mx55uij4mimwi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference